September 1, 1997Clinical CardiologyOpen Access

Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction

View Full Paper

Ask AI

Bookmark

Population

Patients who survive an acute myocardial infarction at high risk of sudden death, including those with…

Design

Review

Authors

RUR. Dent UnderwoodKent and Sussex Hospital JSJasbír SraAurora Health Care MAMasood AkhtarBahauddin Zakariya University

Discussion

Member takes

Implication

Supports ICDs and beta-blockers in high-risk patients; leaves open optimal antiarrhythmic strategies in contemporary settings.

Structured PICO

Population

Patients who survive an acute myocardial infarction at high risk of sudden death, including those with sustained or nonsustained ventricular arrhythmia, significant left ventricular dysfunction, late potentials, high-grade ventricular ectopy, and abnormal heart rate variability

Intervention

Evaluation (electrophysiologic studies) and treatment strategies (implanted defibrillators, antiarrhythmic drugs, beta-blockers, ACE inhibitors, carvedilol, losartan)

This review highlights the survival benefits of implanted defibrillators and beta-blockers in high-risk post-MI patients, contrasting with the potential harm of many antiarrhythmic drugs.

Cite This Study

Underwood et al. (1997) studied this question.

synapsesocial.com/papers/6a20916bf5435ee87fb41b57 https://doi.org/10.1002/clc.4960200908

Topics

Ventricular arrhythmias

View Full Paper

Ask AI

Bookmark

Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider